Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity--a prospective and blinded study
- PMID: 20593209
- DOI: 10.1007/s00784-010-0434-6
Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity--a prospective and blinded study
Abstract
The aim of this study was to evaluate the diagnostic accuracy of oral brush biopsy to identify early malignancy. One hundred and eighty-six brush biopsies of suspicious mucosal lesions were obtained, haematoxilin and eosin (H&E)-stained and compared with the histology of conventional excision biopsies of the same site performed concomitantly. The sensitivity for identifying squamous cell carcinoma (SCC) was 88.5%. High-risk lesions including squamous intraepithelial neoplasia (SIN II, SIN III) and SCC were identified with a sensitivity of 86.4%, using a pap-analogous classification, which is considered to be carcinomatous, as well as moderate and severe dysplastic cells positive. Depending on the cytopathologic definition for malignancy and the tumour size, the test accuracy varied: Extending the cytopathologic criteria for malignancy by defining all dysplastic or malignant cytopathologic findings as positive, the sensitivity was increased to 95.2% at the expense of the specificity, which was reduced from 94.9% to 82.3%. Separately analysing SCCs of less than 20 mm, the sensitivity was reduced by 9.5% to 78%. Although small malignant lesions seem to be less reliable by the conventional oral brush biopsy, it is a useful screening instrument for early diagnosis of suspicious, epithelial lesions and could therefore contribute to improved cancer prognosis.
Similar articles
-
Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy.Oral Oncol. 2013 May;49(5):420-6. doi: 10.1016/j.oraloncology.2012.12.006. Epub 2013 Jan 11. Oral Oncol. 2013. PMID: 23318121
-
Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):535-40. doi: 10.1067/moe.2001.112949. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001. PMID: 11346731
-
Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial.Clin Oral Investig. 2011 Dec;15(6):975-82. doi: 10.1007/s00784-010-0455-1. Epub 2010 Aug 17. Clin Oral Investig. 2011. PMID: 20714910 Clinical Trial.
-
[Usefulness of oral exfoliative cytology for the diagnosis of oral squamous dysplasia and carcinoma].Minerva Stomatol. 2004 Mar;53(3):77-86. Minerva Stomatol. 2004. PMID: 15107778 Review. Italian.
-
Treatment of Oral Dysplasia.Dent Clin North Am. 2024 Jan;68(1):133-149. doi: 10.1016/j.cden.2023.07.008. Epub 2023 Aug 23. Dent Clin North Am. 2024. PMID: 37951630 Review.
Cited by
-
Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.Klin Padiatr. 2012 Apr;224(3):132-8. doi: 10.1055/s-0032-1308989. Epub 2012 Apr 13. Klin Padiatr. 2012. PMID: 22504776 Free PMC article. Review.
-
Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association.J Am Dent Assoc. 2017 Nov;148(11):797-813.e52. doi: 10.1016/j.adaj.2017.08.045. J Am Dent Assoc. 2017. PMID: 29080605 Free PMC article.
-
Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.Int J Nanomedicine. 2014 Aug 8;9:3719-35. doi: 10.2147/IJN.S61670. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25143724 Free PMC article.
-
Identification and validation of seven prognostic long non-coding RNAs in oral squamous cell carcinoma.Oncol Lett. 2020 Jul;20(1):939-946. doi: 10.3892/ol.2020.11603. Epub 2020 May 13. Oncol Lett. 2020. PMID: 32566023 Free PMC article.
-
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD010276. doi: 10.1002/14651858.CD010276.pub3. Cochrane Database Syst Rev. 2021. PMID: 34282854 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials